Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B MacLean

Showing results (231-240 of 233) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 233 results.
Endocrine|April 27, 2001
Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogueL C Pan, P A Carpino, B A Lefker, et al.
JAMA Oncology|January 20, 2022
Evidence-Based Clinical Practice Guidelines for Extramammary Paget DiseaseNour Kibbi, Joshua L Owen, Brandon Worley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder CancerJohn L Gore, Erika M Wolff, Michael G Nash, et al.
Pageof 24

Showing results (231-240 of 233) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 233 results.
Endocrine|April 27, 2001
Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogueL C Pan, P A Carpino, B A Lefker, et al.
JAMA Oncology|January 20, 2022
Evidence-Based Clinical Practice Guidelines for Extramammary Paget DiseaseNour Kibbi, Joshua L Owen, Brandon Worley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder CancerJohn L Gore, Erika M Wolff, Michael G Nash, et al.
Pageof 24